2) Notably, notice how #DeltaPlus is gaining ground against old Delta in both those with or without any recent travel history. This means community transmission is definitely taking hold. Not good.
3) It seems #deltaplus#AY42 has similar rates of ER visits and hospital admissions in England so far. Though numbers still too low to know for sure yet.
4) Mortality rates for #deltaplus and old #deltavariant among cases is similar too. Good so far. But keep in mind Delta itself if 2-4 times more severe than old Wuhan #COVID19
5) But here is the faster transmission seen in the SECONDARY ATTACK RATE in non-traveler households— for old #deltavariant it’s 11.2%. For new #Deltaplus#AY42, it’s 12.2%. It looks small but it’s significantly higher.
6) Leaders in Wales 🏴 say #deltaplus is 10% more transmissible and 10% more severe. I’m curious where their 10% more severe comes from but I’m not ruling it out. Wales could have more data than England.
📍28 days later. Welcome to @BorisJohnson’s 🇬🇧 dystopian domain. There are almost no mitigations anymore. Deaths surging every week… now with #DeltaVariant & new #DeltaPlus surging unchecked. What a cluster.
3) UK is only winning… if you compare yourself to Eastern Europe and Russia 🇷🇺— @BorisJohnson’s comrade in the pandemic is now closer to Putin. At least Moscow is sober enough to know when to enter a lockdown. But Boris and @sajidjavid have no courage to save lives.
⚠️BREAKING—REINFECTION & NATURAL IMMUNITY—new CDC study in hospitalized adults finds: unvaccinated people with prior #COVID19 infection recently were **5 times more likely** to be reinfected / get breakthrough versus people recently fully vaccinated! 🧵 cdc.gov/mmwr/volumes/7…
2) Here’s the background—
Previous infection with SARS-CoV-2 or COVID-19 vaccination can provide immunity and protection against subsequent SARS-CoV-2 infection and illness. ➡️ but the big debate has been which immunity is stronger? Offers more protection? That’s the study aim.
3) “Among COVID-19–like illness hospitalizations among adults aged ≥18 years whose previous infection or vaccination occurred 90–179 days earlier, odds of laboratory-confirmed #COVID19 among unvaccinated adults with previous SARS-CoV-2 infection were 5.49-fold higher”…
💡WOW—a cheap generic anti-depressant Fluvoxamine that costs just $4 reduced #COVID19 hospitalizations risk by ~30%… or from 16% in placebo to 11% in drug group. It even reduced mortality by 91%! #Fluvoxamine 🧵
2) Because it has already been approved by the FDA for mental health treatment, doctors can begin to prescribe it under certain parameters. The relatively modest cost means it could be highly beneficial in parts of the world with few resources. washingtonpost.com/science/2021/1…
3) The study, published Wednesday in the Lancet journal, found that giving high-risk covid-19 patients fluvoxamine — 100 mg twice daily for 10 days — early in their treatment reduced the need for hospitalization. thelancet.com/journals/langl…
OMG—best 2 min all day—“Going extinct is a bad thing. But driving yourselves extinct? In 70 million years, that the most ridiculous thing I ever heard! At least we had an asteroid—what’s your excuse?!” scolds @frankiethedino. #DontChooseExtinction HT @UNDP